UNSPSC 51283726: Cefuroxime sodium

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier R8A7M9MY61. European Medicines Agency schedules Cefuroxime sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01140MIG. Cefuroxime sodium generally arises in the molecular formula C16H15N4NAO8S. The term 'cefuroxime sodium' is a U.S. Pharmacopeial Convention designation. Most nations, for tariff and trade purposes, schedule cefuroxime sodium under HS 29419000 and SITC 54139.

As of Q4 2014, CEFUROXIME SODIUM remains US FDA's Preferred Term for this commodity. Cefuroxime sodium bears US NLM identifiers UMLS ID C0701852 and NCI Concept Code C47439. SMILES: CO/N=C(/C1CCCO1)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)N)C(=O)[O-].[NA+].

UNSPSC 51283726 Cefuroxime sodium is a Commodity code that maps to pharmaceutical supply contracting, though recent state and local opportunities tagged under this code show little direct activity for cefuroxime itself. Instead, the tagged solicitations reflect broader pharmaceutical procurement — including antibiotic tablets, naloxone, and drug deactivation systems — suggesting state and local agencies use this code or related pharmaceutical codes as catch-all designators for emergency-response and public-health drug inventories rather than product-specific purchasing. State and local health departments and county public-health agencies are the primary issuing bodies under pharmaceutical supply codes, typically leveraging cooperative purchasing vehicles such as MMCAP Infuse and piggyback contracts to consolidate volume and reduce unit costs. Contracts generally require quarterly or regular deliveries to centralized distribution points, vendor compliance with drug-free workplace and E-Verify requirements, insurance and bonding, and fixed-fee or unit-price structures with multi-year renewal options.

The Illinois Department of Public Health awarded a $2,999,999.11 piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026, for pharmaceutical warehouse supply (doxycycline and ciprofloxacin tablets); Seminole County, Florida issued an IFB in June 2026 for 1,900 units of naloxone and 800 drug deactivation systems annually with a July 26, 2023 response deadline, indicating a two-year initial term with renewal options and quarterly delivery to a county health building. Recent activity concentrates in Florida and Illinois. Prospective vendors should expect state-level health departments and county health and emergency-services agencies as primary buyers, cooperative purchasing as the standard vehicle for volume buys, and compliance requirements centered on pharmaceutical handling, E-Verify, and federal environmental regulations when FEMA funding is involved.